| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |